Yearly Archives: 2016

The staged acquisition of Phagenesis by Nestlé Health Science will benefit patients with dysphagia

September 2016

Manchester, England, 1 September 2016 – Nestlé Health Science (NHSc) and Phagenesis announced today that NHSc is entering into a staged, milestone-based acquisition of Phagenesis, a medical device company that has developed a new treatment for dysphagia. Under the terms … Continue reading

Posted in news | Comments Off on The staged acquisition of Phagenesis by Nestlé Health Science will benefit patients with dysphagia